The year 2025 has been a landmark for international cannabis reform, particularly in Europe and Oceania. Following Germany's pioneering Cannabis Act, imports of medical cannabis into the country jumped significantly, with 2025 projections suggesting a move toward 100 tons annually. This growth is largely driven by the removal of tender requirements for domestic cultivation and the widespread adoption of Telemedicine, which now facilitates over 150,000 patient visits per month in Germany alone.

Similarly, the Australian medical market continues to expand, though 2025 has seen increased regulatory scrutiny regarding "High-Volume Telehealth" models. For a breakdown of the evolving EU-GMP (Good Manufacturing Practice) and GACP (Good Agricultural and Collection Practice) standards that govern these international trade routes, the Legal Marijuana Market research offers a comprehensive jurisdictional analysis. These regulations are creating a two-tiered pricing structure, where EU-GMP certified flower commands a significant premium over non-certified imports due to its verified safety and potency profiles.